Chicago IL 小细胞肺癌临床试验
12项针对 小细胞肺癌的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- University of Chicago Medical Center /ID# 280149, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
招募中1/2 期
- University of Chicago ( Site 1108), Chicago
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
招募中2 期
- Northwestern, Chicago
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
招募中3 期
- Rush MD Anderson Cancer Center, Chicago
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
招募中1 期
- University of Illinois Chicago, Chicago
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
招募中2 期
- University of Illinois Chicago, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- The University of Chicago Medical Center (UCMC), Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
招募中2 期
- University of Illinois Cancer Center, Chicago
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
招募中2 期
- Northwestern University, Chicago
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
招募中1/2 期
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
招募中2 期
- University of Chicago Medicine, Chicago
其他城市的 小细胞肺癌试验
- Houston, TX26 项研究
- Arlington, VA23 项研究
- Boston, MA21 项研究
- New York City, NY21 项研究
- Nashville, TN20 项研究
- Los Angeles, CA20 项研究
- Orlando, FL15 项研究
- Dallas, TX13 项研究
- St. Louis, MO13 项研究
- Cleveland, OH13 项研究
- Detroit, MI12 项研究
- Washington, DC12 项研究
Chicago的其他研究
- 非小细胞肺癌61 项研究
- 乳腺癌58 项研究
- 癌症（所有类型）51 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肥胖症41 项研究
- 肺癌41 项研究
- 卵巢癌36 项研究
- 卒中34 项研究
- 结直肠癌33 项研究
- 心力衰竭31 项研究
- 超重28 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。